Αποτελέσματα Αναζήτησης
13 Ιουλ 2020 · In June 2016, the government’s Resolution 1587 adopted a definition of ‘cannabis for medical and research purposes’, which ensures access to and supply of medical grade cannabis on the one hand and control of cannabis products which are still defined as ‘narcotic drugs’ on the other.
Background. Cannabis is not registered as a pharmaceutical (medication), and it is currently defined as a “dangerous drug” according to both the Dangerous Drugs Ordinance [New Version], 5733—1973 and the 1961 UN Single Convention on Narcotic Drugs, to which Israel is a signatory.
In addition to the Convention, local laws, an ordinance, government resolutions, and official procedures regulate Israel’s medical cannabis industry. The 1977 Penal Law sits at the heart of criminal law in Israel, and addresses the matter of drugs, including cannabis, although mainly within the context of convictions.
8 Αυγ 2023 · Israel's new reforms for medicinal cannabis will remove a lot of the heavy regulations in the sector, making it more accessible and boosting new research.
14 Ιαν 2024 · How Israel became the world leader in medical marijuana. From pioneering research to a rise in medicinal cannabis patients
11 Αυγ 2023 · The key aspects of the regulatory reform are the following: Starting December 29, 2023, patients with a wide range of diseases and medical conditions will no longer be required to obtain a...
8 Φεβ 2022 · The article will address: Research licensing in the field of medical cannabis. Recent updates in the medical cannabis field. Approval of new indications for treatment with medical cannabis.
